Scott L Burrows, CFO at Arcutis Biotherapeutics, holds 116.42K shares in Spyre Therapeutics (Ticker: SYRE), holds 59.12K shares in Arcutis Biotherapeutics (Ticker: ARQT). Most recently, Scott L Burrows Sold ― shares of Spyre Therapeutics on Sep 05, 2024 for an estimated value of 522.02K.
What is the percentage of profitable transactions made by Scott L Burrows?
The percentage of profitable transactions made by Scott L Burrows is ―.
What is the average return per transaction made by Scott L Burrows?
The average return per transaction made by Scott L Burrows is ―.
What stocks does Scott L Burrows hold?
Scott L Burrows holds: ARQT, SYRE stocks.
What was Scott L Burrows’s latest transaction?
Scott L Burrows latest transaction was an Informative Sell of $522.02K.
What was Scott L Burrows's most profitable transaction?
Scott L Burrows’s most profitable transaction was an Informative Sell of SYRE stock on September 5, 2024. The return on the trade was -1.60%.
What is Scott L Burrows's role in Arcutis Biotherapeutics?
Scott L Burrows's role in Arcutis Biotherapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.